BTCS Inc. announces $10 million convertible notes issuance at a 198% premium, part of its DeFi/TradFi funding strategy. BTCS Inc. has announced the issuance of approximately $10 million in convertible ...

Nebius Group N.V. ("Nebius Group" or the "Company"; NASDAQ: NBIS), a leading AI infrastructure company, today announced the pricing of its offering of $4.0 billion aggregate original principal amount ...

CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced the pricing of $550 million aggregate principal amount ...

Ormat (ORA) boosts 2031 convertible note sale to $975.7M; see pricing, conversion premium, and planned buybacks to offset dilution—read now.

Duke Energy (DUK) announced the pricing of $1.3 billion in convertible senior notes due in 2029 through a private placement. This amount is higher than the previously stated $1 billion. The initial ...

CRISPR Therapeutics (CRSP) upsized a $550M convertible notes deal due 2031 at 1.125%, with a 45% conversion premium—get the key terms now.

Company entered into capped call transactions to increase effective conversion premium to 100% Company to repurchase approximately 334,000 ...

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) (“Omeros” or the “Company”) today announced that it has entered into exchange agreements (the “Exchange Agreements”) with a limited number ...

Xometry, Inc. announced the successful closing of a $250 million offering of convertible notes due in 2030, aimed at refinancing existing debt and improving financial flexibility. The company intends ...